Oracle Health Clinical AI Agent vs Suki
This is the sharpest version of one question in the category: who should be allowed to turn a conversation into an order, and what have they published about getting it wrong. Both do it. The Oracle agent drafts prescriptions, labs, imaging and follow ups natively inside its own record system. Suki stages orders through a voice command layer across Epic, Oracle Health, athenahealth and MEDITECH. Neither publishes a command or order accuracy rate, a confidence threshold or an escalation behaviour, which is a real gap on both sides. Suki at least publishes a named SOC 2 Type 2, a trust centre and specific de identification mechanics, and it works across four record systems rather than one. The agent is deeper where it lives and unavailable everywhere else. On an Oracle estate, run the pilot on order accuracy and nothing else.
- Native to Oracle Health, with orders written back as structured data rather than staged in a third party layer, and no separate integration, login or vendor to onboard.
- The order set is broader than a command layer: prescriptions, laboratory tests, imaging studies and follow up appointments inferred from patient history and clinician favourites, drafted from the conversation itself.
- It is inside an existing enterprise agreement, so the security review, support path and contracting are already done, which frequently decides this evaluation regardless of what the published evidence says.
- It is not tied to one record system. Deep bidirectional integrations across Epic, Oracle Health, athenahealth and MEDITECH, plus partner routes to MEDENT, Azalea Health and WellSky, and a developer platform other vendors embed.
- The privacy engineering is specific rather than asserted: clinician and patient are not identified in voice recordings, no voice signatures are created or retained, recordings are de identified by chunking and identifiers are removed from text transcripts.
- Named security posture. A trust centre at trust.suki.ai and a SOC 2 Type 2 claim that specifies its type, against an agent with no product level attestation published at all.
Side by Side
| Axis | O Oracle Health Clinical AI Agent |
S Suki |
|---|---|---|
| AI Centrality | ||
| Autonomy and Oversight Model | ||
| Model and Technology Transparency | ||
| Clinical and Operational Evidence | ||
| AI Safety and PHI Stewardship | ||
| HIPAA and BAA Posture | ||
| Security Certifications and Trust Center | ||
| FDA and Regulatory Status | ||
| AI Governance and Bias Disclosure | ||
| EHR and Interoperability Depth | ||
| Deployment Model and Data Residency | ||
| Commercial Transparency | ||
| Setting and Specialty Coverage |
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Ambient Scribes page.
Neither vendor publishes an accuracy rate for interpreting a spoken instruction into an order, an escalation behaviour when an instruction is misheard, or a confidence threshold below which a human must intervene. That is the decisive missing disclosure for both products and should be the substance of any pilot, because a misinterpreted medication instruction is a clinical action rather than a text correction. Neither publishes pricing; Suki offers no free tier and no free trial, and the Oracle agent is not separately priced from the record system contract.